ROCHE HOLDING AG-BR (RHO.DE) Stock Fundamental Analysis
Europe - FRA:RHO - CH0012032113 - Common Stock
325 EUR
-0.8 (-0.25%)
Overall RHO gets a fundamental rating of 6 out of 10. We evaluated RHO against 54 industry peers in the Pharmaceuticals industry. While RHO has a great profitability rating, there are some minor concerns on its financial health. RHO is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
RHO had positive earnings in the past year.
In the past year RHO had a positive cash flow from operations.
In the past 5 years RHO has always been profitable.
Each year in the past 5 years RHO had a positive operating cash flow.
1.2 Ratios
RHO's Return On Assets of 9.95% is fine compared to the rest of the industry. RHO outperforms 70.37% of its industry peers.
RHO has a Return On Equity of 32.88%. This is amongst the best in the industry. RHO outperforms 83.33% of its industry peers.
RHO has a Return On Invested Capital of 24.24%. This is amongst the best in the industry. RHO outperforms 90.74% of its industry peers.
RHO had an Average Return On Invested Capital over the past 3 years of 23.72%. This is significantly above the industry average of 14.51%.
The 3 year average ROIC (23.72%) for RHO is below the current ROIC(24.24%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.95% | ||
| ROE | 32.88% | ||
| ROIC | 24.24% |
ROA(3y)11.64%
ROA(5y)13.32%
ROE(3y)36.55%
ROE(5y)41.17%
ROIC(3y)23.72%
ROIC(5y)23.71%
1.3 Margins
The Profit Margin of RHO (15.31%) is comparable to the rest of the industry.
RHO's Profit Margin has declined in the last couple of years.
RHO has a better Operating Margin (33.79%) than 85.19% of its industry peers.
In the last couple of years the Operating Margin of RHO has remained more or less at the same level.
RHO has a Gross Margin of 73.92%. This is in the better half of the industry: RHO outperforms 66.67% of its industry peers.
In the last couple of years the Gross Margin of RHO has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 33.79% | ||
| PM (TTM) | 15.31% | ||
| GM | 73.92% |
OM growth 3Y4.01%
OM growth 5Y0.18%
PM growth 3Y-14.88%
PM growth 5Y-9.03%
GM growth 3Y2.22%
GM growth 5Y0.6%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so RHO is creating value.
The number of shares outstanding for RHO has been reduced compared to 1 year ago.
Compared to 5 years ago, RHO has less shares outstanding
The debt/assets ratio for RHO is higher compared to a year ago.
2.2 Solvency
RHO has an Altman-Z score of 4.32. This indicates that RHO is financially healthy and has little risk of bankruptcy at the moment.
RHO has a better Altman-Z score (4.32) than 64.81% of its industry peers.
The Debt to FCF ratio of RHO is 2.50, which is a good value as it means it would take RHO, 2.50 years of fcf income to pay off all of its debts.
RHO has a Debt to FCF ratio of 2.50. This is in the better half of the industry: RHO outperforms 70.37% of its industry peers.
A Debt/Equity ratio of 1.06 is on the high side and indicates that RHO has dependencies on debt financing.
RHO's Debt to Equity ratio of 1.06 is on the low side compared to the rest of the industry. RHO is outperformed by 70.37% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.06 | ||
| Debt/FCF | 2.5 | ||
| Altman-Z | 4.32 |
ROIC/WACC5.14
WACC4.72%
2.3 Liquidity
A Current Ratio of 1.29 indicates that RHO should not have too much problems paying its short term obligations.
RHO has a Current ratio (1.29) which is comparable to the rest of the industry.
A Quick Ratio of 1.02 indicates that RHO should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.02, RHO is doing good in the industry, outperforming 61.11% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.29 | ||
| Quick Ratio | 1.02 |
3. Growth
3.1 Past
RHO shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.19%.
Measured over the past years, RHO shows a decrease in Earnings Per Share. The EPS has been decreasing by -1.39% on average per year.
Looking at the last year, RHO shows a small growth in Revenue. The Revenue has grown by 4.77% in the last year.
RHO shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.32% yearly.
EPS 1Y (TTM)5.19%
EPS 3Y-1.73%
EPS 5Y-1.39%
EPS Q2Q%8.5%
Revenue 1Y (TTM)4.77%
Revenue growth 3Y-1.24%
Revenue growth 5Y-0.32%
Sales Q2Q%3.67%
3.2 Future
Based on estimates for the next years, RHO will show a small growth in Earnings Per Share. The EPS will grow by 6.39% on average per year.
The Revenue is expected to grow by 3.51% on average over the next years.
EPS Next Y5.57%
EPS Next 2Y5.21%
EPS Next 3Y5.44%
EPS Next 5Y6.39%
Revenue Next Year2.13%
Revenue Next 2Y2.43%
Revenue Next 3Y2.75%
Revenue Next 5Y3.51%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 15.24, which indicates a correct valuation of RHO.
61.11% of the companies in the same industry are more expensive than RHO, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 25.56. RHO is valued slightly cheaper when compared to this.
The Price/Forward Earnings ratio is 14.41, which indicates a correct valuation of RHO.
RHO's Price/Forward Earnings is on the same level as the industry average.
RHO is valuated cheaply when we compare the Price/Forward Earnings ratio to 34.62, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.24 | ||
| Fwd PE | 14.41 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of RHO is on the same level as its industry peers.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of RHO indicates a somewhat cheap valuation: RHO is cheaper than 64.81% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 18.38 | ||
| EV/EBITDA | 11.36 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of RHO may justify a higher PE ratio.
PEG (NY)2.73
PEG (5Y)N/A
EPS Next 2Y5.21%
EPS Next 3Y5.44%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 3.35%, RHO has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.01, RHO pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.44, RHO pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.35% |
5.2 History
The dividend of RHO has a limited annual growth rate of 2.37%.
Dividend Growth(5Y)2.37%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
RHO pays out 85.87% of its income as dividend. This is not a sustainable payout ratio.
RHO's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP85.87%
EPS Next 2Y5.21%
EPS Next 3Y5.44%
FRA:RHO (11/17/2025, 7:00:00 PM)
325
-0.8 (-0.25%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners40.11%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap263.01B
Revenue(TTM)61.59B
Net Income(TTM)9.43B
Analysts70.37
Price Target336.47 (3.53%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.35% |
Yearly Dividend11
Dividend Growth(5Y)2.37%
DP85.87%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.1%
PT rev (3m)-3.23%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.45%
EPS NY rev (3m)-4.67%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.31%
Revenue NY rev (3m)-0.6%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.24 | ||
| Fwd PE | 14.41 | ||
| P/S | 3.94 | ||
| P/FCF | 18.38 | ||
| P/OCF | 12.58 | ||
| P/B | 8.46 | ||
| P/tB | 55.83 | ||
| EV/EBITDA | 11.36 |
EPS(TTM)21.32
EY6.56%
EPS(NY)22.56
Fwd EY6.94%
FCF(TTM)17.68
FCFY5.44%
OCF(TTM)25.83
OCFY7.95%
SpS82.5
BVpS38.41
TBVpS5.82
PEG (NY)2.73
PEG (5Y)N/A
Graham Number135.75
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.95% | ||
| ROE | 32.88% | ||
| ROCE | 30.98% | ||
| ROIC | 24.24% | ||
| ROICexc | 24.24% | ||
| ROICexgc | 36.85% | ||
| OM | 33.79% | ||
| PM (TTM) | 15.31% | ||
| GM | 73.92% | ||
| FCFM | 21.43% |
ROA(3y)11.64%
ROA(5y)13.32%
ROE(3y)36.55%
ROE(5y)41.17%
ROIC(3y)23.72%
ROIC(5y)23.71%
ROICexc(3y)28.94%
ROICexc(5y)29.11%
ROICexgc(3y)49.53%
ROICexgc(5y)49.86%
ROCE(3y)29.26%
ROCE(5y)30.68%
ROICexgc growth 3Y2.54%
ROICexgc growth 5Y-3.21%
ROICexc growth 3Y1.27%
ROICexc growth 5Y-3.5%
OM growth 3Y4.01%
OM growth 5Y0.18%
PM growth 3Y-14.88%
PM growth 5Y-9.03%
GM growth 3Y2.22%
GM growth 5Y0.6%
F-Score8
Asset Turnover0.65
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.06 | ||
| Debt/FCF | 2.5 | ||
| Debt/EBITDA | 1.27 | ||
| Cap/Depr | 195% | ||
| Cap/Sales | 9.87% | ||
| Interest Coverage | 17.17 | ||
| Cash Conversion | 80.58% | ||
| Profit Quality | 140.01% | ||
| Current Ratio | 1.29 | ||
| Quick Ratio | 1.02 | ||
| Altman-Z | 4.32 |
F-Score8
WACC4.72%
ROIC/WACC5.14
Cap/Depr(3y)132.99%
Cap/Depr(5y)129.62%
Cap/Sales(3y)7.8%
Cap/Sales(5y)8.42%
Profit Quality(3y)129.49%
Profit Quality(5y)117.9%
High Growth Momentum
Growth
EPS 1Y (TTM)5.19%
EPS 3Y-1.73%
EPS 5Y-1.39%
EPS Q2Q%8.5%
EPS Next Y5.57%
EPS Next 2Y5.21%
EPS Next 3Y5.44%
EPS Next 5Y6.39%
Revenue 1Y (TTM)4.77%
Revenue growth 3Y-1.24%
Revenue growth 5Y-0.32%
Sales Q2Q%3.67%
Revenue Next Year2.13%
Revenue Next 2Y2.43%
Revenue Next 3Y2.75%
Revenue Next 5Y3.51%
EBIT growth 1Y10.03%
EBIT growth 3Y2.72%
EBIT growth 5Y-0.14%
EBIT Next Year25.3%
EBIT Next 3Y10.44%
EBIT Next 5Y9.08%
FCF growth 1Y12.91%
FCF growth 3Y-2.8%
FCF growth 5Y-2.91%
OCF growth 1Y19.07%
OCF growth 3Y-1.42%
OCF growth 5Y-2.14%
ROCHE HOLDING AG-BR / RHO.DE FAQ
Can you provide the ChartMill fundamental rating for ROCHE HOLDING AG-BR?
ChartMill assigns a fundamental rating of 6 / 10 to RHO.DE.
Can you provide the valuation status for ROCHE HOLDING AG-BR?
ChartMill assigns a valuation rating of 5 / 10 to ROCHE HOLDING AG-BR (RHO.DE). This can be considered as Fairly Valued.
How profitable is ROCHE HOLDING AG-BR (RHO.DE) stock?
ROCHE HOLDING AG-BR (RHO.DE) has a profitability rating of 8 / 10.
What is the expected EPS growth for ROCHE HOLDING AG-BR (RHO.DE) stock?
The Earnings per Share (EPS) of ROCHE HOLDING AG-BR (RHO.DE) is expected to grow by 5.57% in the next year.
How sustainable is the dividend of ROCHE HOLDING AG-BR (RHO.DE) stock?
The dividend rating of ROCHE HOLDING AG-BR (RHO.DE) is 4 / 10 and the dividend payout ratio is 85.87%.